Clinical Trial Update: Cardiomodulatory Effects of Gender-Affirming Hormone Therapy

View source ↗

Summary

An update on a clinical trial examining the cardiomodulatory effects of gender-affirming hormone therapy in people with gender dysphoria and cardiovascular risk…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• Gender Dysphoria

Drugs mentioned

• ESTRADIOL (Estradiol)
• TESTOSTERONE (testosterone)

Snippet

Sponsor: University Hospital, Akershus | Conditions: Gender Incongruence, Cardiovascular Disease (CVD) Risk Factors | Status: ENROLLING_BY_INVITATION